Back to search
FDAFDA · Food and drugs·Recall number D-0168-2021

TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10

Published December 23, 2020 · Recall initiated: December 7, 2020

Summary

FDA records drug Class I recall D-0168-2021, published December 23, 2020 and initiated December 7, 2020. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 14368 bottles; Lot: Lot: 36783 Exp. 06/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVKARE Inc.
Distributor
Nationwide within the U.S.
Lot
Lot: 36783 Exp. 06/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10 recalled?

Yes. FDA published recall D-0168-2021 on December 23, 2020. Reported hazard: Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter